Hot Topics · Cross-industry
Surgical Robotics Adoption
Robotic platform placements, utilization and procedure volume growth.
AI-generated · informational only · not investment advice · verify before relying.
01 · The lede
Intelligence brief
SeventhBiz Intelligence
Refreshed 3h agoSurgical robotics has crossed from clinical validation to infrastructure scaling across the medical device industry, with six tracked companies now reporting material commercial acceleration and three entering or accelerating competitive market entry. ISRG's 28% system placement growth and 15% procedure volume expansion anchor the market expansion, but the investment thesis hinges on the structural shift: GMED's 73% unit deployment acceleration, ZBH's imminent Monogram launch with 80-90% addressable non-robotic surgeon population, and JNJ's FDA-cleared OTTAVA entry directly signal that adoption is now capacity-constrained and payer-dependent, not surgeon-adoption-constrained.…
The full brief is part of the subscription
03 · Companies
Companies engaging with this topic
Tracked companies with an on-record signal on Surgical Robotics Adoption this cycle.
06 · Evidence
Recent mentions
Preview“our overall EGPS and eHub units deployed, whether sold, leased or rented, grew 73% versus the prior year quarter.”
Keith Pfeil prepared remarks — Enabling Technologies
“The market for our Enabling Technologies in spine, cranial and orthopedic surgery is still in its infancy stage and consists primarily of INR systems.”
MD&A — Overview, Enabling Technologies
“deploying 73% more robot and navigation units as compared to the prior year quarter, reflecting continued strong demand for our technology and execution against our capital deployment plan”
Press Release — CEO Commentary
Unlock Surgical Robotics Adoption
The full intelligence brief, how the language shifted quarter over quarter, the bear case, and every company mention — verbatim and source-cited.